General Information of This Metabolic Reaction (MR) (ID:
MR009649) |
Formula |
|
Reactant |
Zopiclone |
Product |
Zopiclone N-oxide |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 3A4 (CYP3A4)
|
DME Info
|
Cytochrome P450 2C9 (CYP2C9)
|
DME Info
|
Cytochrome P450 2C8 (CYP2C8)
|
DME Info
|
Metabolic Type
|
Oxidation
-
N-oxidation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Produce The Product of This MR
|
|
Other MR(s) That Metabolize The Produtc of This MR
|
|
References |
1 |
Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.
|
2 |
Distribution of zopiclone and main metabolites in hair following a single dose
|
3 |
Development of a novel tandem mass spectrometry method for the quantification of eszopiclone without interference from 2-amino-5-chloropyridine and application in a pharmacokinetic study of rat J Pharm Biomed Anal. 2020 Sep 5;188:113363. doi: 10.1016/j.jpba.2020.113363.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.